PRISM Stock IndexesCurrent Value% Change (Daily)% Change (Inception)Most ActiveTop % GainersTop % Losers
Cannabis$73.30-2.4%-26.7%TLRY 15,391CLVR 8.955%HITI -7.627%
EV$44.20-0.9%-55.8%GOEV 21,230DCRD 40.516%GOEV -16.373%
Gene Therapy$50.00-4.2%-50.0%FATE 4,185SLDB 3.846%WVE -10.377%
MedDevices$172.50-1.1%72.5%ATRS 5,230ADMP 14.613%AXNX -8.387%
MedDiagnostics$91.80-2.8%-8.2%OPK 3,271BSGM 14.563%BMRA -16.592%
Solar$73.00-2.8%-27.0%HYSR 9,213OEG 8.084%CSIQ -8.509%
Uranium$87.50-1.3%-12.5%UEC 7,341STTDF 9.677%AUEEF -20%
Vaccines & Cell Therapy$148.30-2%48.3%SRNE 36,504ATHX 21.186%IBIO -16.667%
Web 3.0$35.20-7.8%-64.8%MARA 34,496SNII 3.33%DEFTF -20.091%
Zombie$184.60-2.2%84.6%AMC 35,277GME 35.241%RDFN -8.541%
(Reuters) – Private equity firms that acquired companies since the banking crisis started on March 8 have funded the deals mostly with their own funds,… [Read More]

Prism Daily

Investors Prism Econ Outlook: Fed Meeting Today at 2pm ET – Expectations, Concerns & Equity MarketWatch

Any investor with a pulse on the market has likely been listening to the chatter surrounding the upcoming Fed meeting today. The Fed statement is expected for 2pm ET on Wednesday and Chairman Powell is scheduled to speak at 2:30pm…

GameStop soars on short squeeze after swinging to profit, meme stocks rally

March 22 (Reuters) - Meme stock GameStop Corp (GME.N) jumped nearly 50% in early trading on Wednesday as the video game retailer's first profitable quarter in two years squeezed bearish investors and ignited a surge in other stocks popular among…

Investors Prism Index Mover: Affirm (AFRM) Makes an Affirmative Move in the IP Zombie Index

A leader in the Buy Now Pay Later (BNPL) space is led the pack in the Investors Prism Zombie Index yesterday. Affirm Holdings, Inc. (NASDAQ: AFRM) is a FinTech company who operates a platform for digital and mobile-first commerce in…

Feature Story

SuperCom (NASDAQ: SPCB) Revolutionizing the Criminal Justice Industry

SuperCom Ltd. (SPCB) is a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors. SuperCom presents an impressive group of experts in business, commercial, government identification and wireless technologies, which brings together decades of hands-on experience and expertise. Most recently, the company has launched a $3.6M national electronic monitoring project in Finland.

(more…)

Traders Lens

So far, $SPY has held its 200 Day moving average around 393.

So far, $SPY has held its 200 Day moving average around 393.  The recent sell-ofs seem to be on lower volume and with little follow through.  While the market tone is bearish, smart money would say buy/hold until the 200D MA is decisively broken – it is a very low-risk potential high reward entry level here.

[More Traders Lens]

Prism View

Top Gainers and Losers from the Investors Prism Index

GME was the biggest winner of the entire group and AUEEF was the largest detractor.

GameStop soars on short squeeze after swinging to profit, meme stocks rally

March 22 (Reuters) - Meme stock GameStop Corp (GME.N) jumped nearly 50% in early trading on Wednesday as the video game retailer's first profitable quarter in two years squeezed bearish investors and ignited a surge in other stocks popular among…

SuperCom: Romanian Ministry of Interior Places $7.1M Follow-On Order

SuperCom (Nasdaq: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, has received a follow-on order valued at $7.1 million from Romania's Ministry of Interior for the country's National Electronic Monitoring (EM) Project. The EM…

Asensus Surgical Receives 510(k) Clearance from FDA

Medical device company, Asensus Surgical, Inc., (NYSE American: ASXC), has received 510(k) clearance from the FDA…

Quoin Fortifies Position to Potentially Deliver First Treatment for Netherton Syndrome

In a significant step for the clinical-stage specialty pharmaceutical company and Netherton Syndrome patients, Quoin Pharmaceuticals…

Verde Bio Reports Third Quarter Financial Results; Continues Push Towards Profitability and Growth

Verde Bio Holdings (OTCQB: VHBI) has released its third quarter financial results and provided a corporate…

Investing in Small Companies Offers Big Upside

Why are small-cap stocks a big deal and opportunity for investors right now? They are trading…

Bio View

Connect Biopharma: Phase 2b Data Shows Rapid and Sustained Improvement in Atopic Dermatitis

Global clinical-stage biopharmaceutical company, Connect Biopharma (Nasdaq: CNTB), has announced that post hocdata analysis from its Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD) showed a rapid and sustained improvement in AD signs and symptoms. Connect’s share price…

InMed Demonstrates Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions

Leading cannabinoid researcher, developer and manufacturer, InMed Pharmaceuticals (Nasdaq: INM) has demonstrated the anti-inflammatory potential of rare cannabinoids in skin conditions. The company has sponsored a peer-reviewed scientific study: "Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid…

Aridis Meets Primary and Secondary Endpoints in Cystic Fibrosis Clinical Trial

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) has met the primary and secondary endpoints in safety and pharmacokinetics in a Phase 2a clinical trial evaluating a treatment in cystic fibrosis (CF). Aridis’ lead candidate, AR-501, has received Orphan Drug, Fast Track and…

ThermoGenesis Announces California Facility with Potential for $10-16M Annual Revenue

ThermoGenesis Announces California Facility with Potential for $10-16M Annual Revenue ThermoGenesis Holdings (Nasdaq: THMO) will roll…

Protagonist Therapeutics Delivers Positive Topline Results in Psoriasis Study

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) has received positive topline results in its Phase 2b FRONTIER 1…

Unicycive Successfully Raises $130M To Launch Renazorb For Dialysis Patients

Unicycive Therapeutics, Inc., (Nasdaq: UNCY) has raised up to $130M to support its New Drug Application…

BridgeBio Reports Positive Phase 2 Results; Begins Enrolling Patients in Phase 3 Study

Commercial-stage biopharmaceutical company, BridgeBio (Nasdaq: BBIO), has announced positive results from its PROPEL2 Phase 2 clinical…